Anti-Inflammatory Effects of Glucagon-Like Peptide-1 Receptor Agonists via the Neuroimmune Axis
DNA and Cell Biology · 2024
DOI: 10.1089/dna.2024.0057 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift DNA and Cell Biology, 2024. Verfasst von Susanna Fang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Inflammation, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have shown efficacy in the treatment of metabolic disease-related complications, partially attributable to their anti-inflammatory properties. However, the specific cell types and pathways involved in these effects were not fully understood. A recent study by Wong et al. demonstrated the importance of the brain GLP-1R in mediating the anti-inflammatory effects of GLP-1RAs in Toll-like receptor and sepsis-mediated inflammation. In this discussion, we review the existing literature on the action of GLP-1RAs in inflammation and explore the implications of these recent findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Chi Kin Wong
Zitieren
APA
Fang, S., & Wong, C. K. (2024). Anti-Inflammatory Effects of Glucagon-Like Peptide-1 Receptor Agonists via the Neuroimmune Axis. DNA and Cell Biology. https://doi.org/10.1089/dna.2024.0057
Vancouver
Fang S, Wong CK. Anti-Inflammatory Effects of Glucagon-Like Peptide-1 Receptor Agonists via the Neuroimmune Axis. DNA and Cell Biology. 2024. doi:10.1089/dna.2024.0057
BibTeX
@article{Fang2024,
author = {Fang, Susanna and Wong, Chi Kin},
title = {Anti-Inflammatory Effects of Glucagon-Like Peptide-1 Receptor Agonists via the Neuroimmune Axis},
journal = {DNA and Cell Biology},
year = {2024},
doi = {10.1089/dna.2024.0057}
}
EUVIMED